LenioBio

Developer of a synthetic biology and protein expression technology designed to accelerate and simplify protein expression for complex and novel proteins. The company offers a cell-free eukaryotic expr...

Healthcare

Dusseldorf, Germany

Founded 2016

49 employees

Website

Valuation

$88.3M

Market implied

Share Price

N/A

Total Raised

$51.9M

Last Round

N/A

Investors

+10 other investors

View all 10 investors

Valuation History

0 funding rounds on record

Cap Table

Ownership structure

Market Activity

Secondary transactions

Get the full picture

Create a free account to unlock LenioBio's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required